TomoTherapy Prices High
May 9, 2007 - TomoTherapy Inc., a Madison, Wis.-based developer of cancer treatment systems that use on-board CT imaging and conformal radiation therapy, priced around 11.7 million common shares at $19 per share, for an IPO take of $222.3 million. It had originally planned to offer around 10.94 million shares at between $15 and $17 per share. It will trade on the Nasdaq under ticker symbol TTPY, while Merrill Lynch served as lead underwriter. The company has raised around $79 million in VC funding since 1999, from shareholders like Open Prairie Ventures (6.1%), Venture Investors, Avalon Technology, The Endeavors Group, Ascension Health Ventures and the Wisconsin Alumni Research Foundation.
www.TomoTherapy.com